Prosight Management, LP - CIDARA THERAPEUTICS INC ownership

CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 41 filers reported holding CIDARA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Prosight Management, LP ownership history of CIDARA THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$603,000
+3.3%
358,963
+63.0%
0.30%
+18.8%
Q1 2019$584,000
+1.0%
220,264
-10.4%
0.26%
-14.1%
Q4 2018$578,000
-59.6%
245,764
-24.4%
0.30%
-62.6%
Q3 2018$1,430,000
-76.3%
324,902
-72.0%
0.80%
-82.0%
Q2 2018$6,025,000
+26.9%
1,158,700
-2.3%
4.42%
+48.4%
Q1 2018$4,746,000
-57.6%
1,186,355
-28.0%
2.98%
-63.9%
Q4 2017$11,206,0001,647,8798.24%
Other shareholders
CIDARA THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 1,172,044$2,625,0002.31%
Stonepine Capital Management, LLC 782,817$1,754,0000.80%
5AM Venture Management, LLC 1,134,511$2,541,0000.52%
Omega Fund Management, LLC 2,005,249$4,492,0000.50%
BVF INC/IL 4,776,904$10,700,0000.42%
KNOTT DAVID M 415,308$930,0000.34%
West Family Investments, Inc. 368,910$826,0000.21%
Monashee Investment Management LLC 369,099$827,0000.15%
JEPPSON WEALTH MANAGEMENT, LLC 60,100$134,0000.07%
Pacifica Partners Inc. 8,000$18,0000.01%
View complete list of CIDARA THERAPEUTICS INC shareholders